Redcare Pharmacy revenue and financials
In the fiscal year ended December 2025, Redcare Pharmacy reported revenue of €2.94B (+24.06% year over year). The net loss was €37.7M.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +24.06%
- 2025 vs 2024
- Net margin
- -1.3%
- 2024: -1.9%
How Redcare Pharmacy is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 24.9% a year on average over the last 5 years
Compound annual growth rate: from €968.06M in 2020 to €2.94B in 2025.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −3.9% to −0.7%
Operating income over revenue, 2022 → 2025: 3.2 percentage points.
Shares outstanding up 39.8% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2,941 | 2,371 | 1,799 | 1,204 | 1,060 | 968 | 701 | 540 | 284 | 177 |
| Cost of revenue | 2,278 | 1,825 | 1,358 | 873 | 794 | 749 | 563 | 440 | 226 | 141 |
| Gross profit | 663 | 546 | 440 | 332 | 267 | 220 | 138 | 99.3 | 57.6 | 36.3 |
| Selling, general and administrative | 684 | 585 | 444 | 379 | 299 | 214 | 166 | 127 | 79.8 | 50.1 |
| Operating income | -20.1 | -39.0 | -3.8 | -47.2 | -32.3 | 5.6 | -28.4 | -27.7 | -19.2 | -11.6 |
| EBIT | -20.1 | -39.0 | -3.8 | -47.2 | -32.3 | 5.6 | -28.4 | -27.7 | -19.2 | -11.6 |
| EBITDA | 2.0 | -17.0 | 14.5 | -34.0 | -21.6 | 12.8 | -20.6 | -20.2 | -15.6 | -10.8 |
| Interest expense | 19.9 | 7.8 | 8.0 | 8.5 | 8.6 | 10.8 | 7.5 | 3.4 | 2.2 | 2.4 |
| Pre-tax income | -47.7 | -47.9 | -14.3 | -84.1 | -77.9 | -15.9 | -42.2 | -34.6 | -21.4 | -21.0 |
| Income tax | -8.3 | -1.5 | -2.7 | -6.5 | -3.7 | 0.8 | -5.9 | -1.0 | -0.0 | -2.5 |
| Net income | -37.7 | -45.5 | -12.0 | -77.6 | -74.2 | -16.8 | -36.3 | -33.6 | -21.4 | -18.4 |
| Net income to common shareholders | -37.7 | -45.5 | -12.0 | -77.6 | -74.2 | -16.8 | -36.3 | -33.6 | -21.4 | -18.4 |
| Basic EPS | -1.87 | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -3.08 |
| Diluted EPS | -1.87 | -2.27 | -0.63 | -4.32 | -4.15 | -1.17 | -2.78 | -2.79 | -2.25 | -3.08 |
| Average shares (basic) | 20.1 | 20.1 | 19.2 | 18.0 | 17.9 | 14.4 | 13.1 | 12.0 | 9.5 | 6.0 |
| Average shares (diluted) | 20.1 | 20.1 | 19.2 | 18.0 | 17.9 | 14.4 | 13.1 | 12.0 | 9.5 | 6.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 847 | 854 | 850 | 795 | 719 | 709 | 717 | 675 | 575 | 561 | 560 | 531 |
| Cost of revenue | 662 | 665 | 672 | 627 | 560 | 541 | 550 | 525 | 441 | 430 | 429 | 410 |
| Gross profit | 185 | 189 | 178 | 168 | 159 | 169 | 167 | 150 | 133 | 131 | 131 | 121 |
| Selling, general and administrative | 173 | 176 | 182 | 179 | 160 | 169 | 176 | 174 | 140 | 134 | 136 | 121 |
| Operating income | 11.8 | 12.2 | -3.5 | -10.8 | -1.1 | 0.2 | -8.5 | -24.1 | -6.5 | -2.9 | -5.4 | 0.3 |
| EBIT | 11.8 | 12.2 | -3.5 | -10.8 | -1.1 | 0.2 | -8.5 | -24.1 | -6.5 | -2.9 | -5.4 | 0.3 |
| EBITDA | 27.8 | 29.1 | 13.5 | -5.3 | 16.1 | 17.5 | 8.3 | -18.6 | 10.6 | 14.2 | 10.9 | 4.9 |
| Interest expense | 8.1 | 7.2 | 7.5 | 13.6 | 8.2 | 10.7 | 4.9 | — | 4.0 | 3.8 | 4.3 | — |
| Pre-tax income | 4.2 | 5.2 | -10.1 | -30.4 | -9.0 | 4.2 | -12.5 | -26.6 | -7.6 | -5.2 | -8.6 | -8.1 |
| Income tax | 3.3 | 1.1 | 0.9 | -1.1 | -1.7 | -4.6 | -0.9 | -0.2 | -0.4 | -0.4 | -0.4 | -1.6 |
| Net income | 0.8 | 4.7 | -10.5 | -29.0 | -7.2 | 9.3 | -10.8 | -26.5 | -6.9 | -4.3 | -7.8 | -5.6 |
| Net income to common shareholders | 0.8 | 4.7 | -10.5 | -29.0 | -7.2 | 9.3 | -10.8 | -26.5 | -6.9 | -4.3 | -7.8 | -5.6 |
| Basic EPS | — | 0.23 | -0.52 | -1.44 | — | 0.46 | -0.54 | -1.30 | — | -0.21 | — | -0.28 |
| Diluted EPS | — | 0.23 | -0.52 | -1.44 | — | 0.46 | -0.54 | -1.30 | — | -0.21 | — | -0.28 |
| Average shares (basic) | — | 20.6 | 20.1 | 20.1 | — | 20.3 | 20.1 | 20.3 | — | 20.0 | — | 20.2 |
| Average shares (diluted) | — | 20.6 | 20.1 | 20.1 | — | 20.3 | 20.1 | 20.3 | — | 20.0 | — | 20.2 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,214 | 1,003 | 1,022 | 729 | 783 | 537 | 428 | 350 | 298 | 120 |
| Current assets | 619 | 500 | 500 | 344 | 433 | 254 | 211 | 136 | 95.4 | 95.6 |
| Cash and equivalents | 92.4 | 96.9 | 84.2 | 66.8 | 247 | 90.5 | 62.7 | 24.3 | 15.8 | 38.5 |
| Short-term investments | 111 | 80.7 | 120 | 113 | 36.4 | 37.8 | 50.6 | 34.4 | 12.5 | 20.0 |
| Receivables | 153 | 125 | 119 | 40.9 | 36.2 | 30.0 | 26.7 | 22.1 | 20.5 | 8.3 |
| Inventory | 214 | 154 | 136 | 99.7 | 96.6 | 81.2 | 56.7 | 43.3 | 40.0 | 18.8 |
| Net property, plant and equipment | 191 | 82.6 | 86.9 | 85.4 | 78.3 | 74.5 | 13.2 | 11.9 | 7.8 | 2.6 |
| Goodwill | 276 | 278 | 277 | 170 | 153 | 129 | 129 | 129 | 126 | 9.1 |
| Other intangible assets | 117 | 134 | 151 | 119 | 104 | 75.5 | 70.7 | 70.6 | 60.5 | 13.1 |
| Long-term investments | 1.5 | 1.4 | 1.3 | 1.3 | 1.5 | 1.8 | 4.0 | 1.4 | 0.9 | — |
| Current liabilities | 400 | 250 | 224 | 119 | 124 | 74.6 | 59.8 | 52.7 | 41.8 | 20.8 |
| Accounts payable | 248 | 175 | 152 | 68.9 | 78.1 | 51.3 | 31.4 | 26.1 | 23.1 | 12.6 |
| Long-term debt | 263 | 210 | 204 | 200 | 195 | 4.1 | 127 | 67.6 | 1.3 | 0.2 |
| Total debt | 417 | 247 | 244 | 235 | 228 | 38.2 | 139 | 78.9 | 7.1 | 0.3 |
| Total liabilities | 735 | 493 | 470 | 375 | 368 | 112 | 195 | 136 | 58.8 | 27.1 |
| Total equity (incl. minority) | 479 | 510 | 552 | 355 | 415 | 425 | 233 | 214 | 239 | 93.2 |
| Retained earnings | -358 | -324 | -279 | -285 | -208 | -134 | -120 | -84.0 | -50.4 | -29.0 |
| Minority interest | 20.0 | 26.0 | 29.8 | 0.0 | — | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,153 | 1,155 | 1,178 | 1,214 | 1,220 | 1,242 | 1,022 | 1,003 | 1,019 | 1,025 | 1,013 | 1,022 |
| Current assets | 548 | 550 | 579 | 619 | 636 | 665 | 515 | 500 | 516 | 516 | 499 | 500 |
| Cash and equivalents | 89.6 | 76.3 | 92.6 | 92.4 | 150 | 94.8 | 104 | 96.9 | 99.4 | 111 | 98.7 | 84.2 |
| Short-term investments | 42.8 | 42.6 | 42.4 | 111 | 121 | 221 | 80.8 | 80.7 | 111 | 120 | 120 | 120 |
| Receivables | 142 | 153 | 156 | 153 | 123 | 119 | 116 | 125 | 105 | 96.7 | 101 | 119 |
| Inventory | 207 | 213 | 215 | 214 | 171 | 162 | 162 | 154 | 142 | 134 | 135 | 136 |
| Net property, plant and equipment | 205 | 206 | 199 | 191 | 170 | 160 | 90.2 | 82.6 | 80.7 | 83.4 | 84.0 | 86.9 |
| Goodwill | — | — | — | 276 | — | — | — | 278 | — | — | — | 277 |
| Other intangible assets | 387 | 388 | 390 | 117 | 403 | 405 | 407 | 134 | 414 | 419 | 423 | 151 |
| Long-term investments | 1.5 | 1.5 | 1.5 | 1.5 | 1.4 | 1.4 | 1.4 | 1.4 | 6.3 | 4.8 | 4.8 | 1.3 |
| Current liabilities | 339 | 347 | 375 | 400 | 378 | 390 | 286 | 250 | 244 | 243 | 226 | 224 |
| Accounts payable | 242 | 252 | 279 | 248 | 230 | 246 | 213 | 175 | 181 | 177 | 161 | 152 |
| Long-term debt | 333 | 331 | 332 | 263 | 304 | 307 | 237 | 210 | 235 | 235 | 235 | 204 |
| Total debt | 355 | 353 | 355 | 417 | 387 | 384 | 247 | 247 | 244 | 244 | — | — |
| Total liabilities | 677 | 680 | 710 | 735 | 698 | 714 | 528 | 493 | 484 | 486 | 470 | 470 |
| Total equity (incl. minority) | 477 | 475 | 468 | 479 | 522 | 529 | 494 | 510 | 535 | 540 | 544 | 552 |
| Retained earnings | — | -362 | — | -358 | — | -330 | — | -324 | — | -290 | — | -279 |
| Minority interest | 18.2 | 17.8 | 18.1 | 20.0 | 19.7 | 19.8 | 19.8 | 26.0 | 29.2 | 26.1 | 28.6 | 29.8 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 31.0 | 22.1 | 61.5 | -29.1 | 11.6 | 17.8 | -30.7 | -14.5 | -23.2 | -17.2 |
| Depreciation and amortization | 29.3 | 29.0 | 24.5 | 18.2 | 15.6 | 9.8 | 10.2 | 9.7 | 3.6 | 0.9 |
| Capital expenditure | -79.3 | -8.7 | -6.4 | -13.6 | -13.8 | -38.2 | -4.0 | -2.8 | -3.1 | -1.0 |
| Investing cash flow | -147 | 8.4 | -60.0 | -138 | -84.3 | -40.2 | -33.4 | -38.6 | -0.9 | -24.5 |
| Financing cash flow | 111 | -17.9 | 15.0 | -13.5 | 230 | 50.2 | 102 | 66.5 | -3.5 | 76.6 |
| Debt issued | 296 | 0.0 | 0.0 | 0.0 | 235 | — | 59.0 | 73.5 | — | — |
| Debt repaid | -167 | -9.9 | -9.0 | -7.1 | -11.4 | -12.5 | -2.5 | -2.2 | — | -27.1 |
| Effect of exchange rates | -0.2 | 0.1 | 0.8 | 0.0 | — | — | — | — | — | — |
| Net change in cash | -4.5 | 12.7 | 17.4 | -181 | 157 | 27.8 | 38.3 | 13.4 | -27.6 | 35.0 |
| Free cash flow | -48.3 | 13.4 | 55.0 | -42.7 | -2.2 | — | — | — | — | — |
| Levered free cash flow | -90.5 | -1.9 | -7.7 | -53.4 | 4.2 | -37.3 | -34.5 | -24.4 | -32.5 | -18.3 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 34.2 | 10.8 | 22.5 | -18.8 | -20.2 | 33.2 | 36.8 | -17.0 | -9.2 | 27.4 | 20.9 | -8.1 |
| Depreciation and amortization | 16.0 | 16.9 | 17.0 | -22.0 | 17.2 | 17.3 | 16.8 | -21.5 | 17.1 | 17.1 | 16.3 | -14.2 |
| Capital expenditure | -3.7 | -13.2 | -12.6 | -26.4 | -14.0 | -26.7 | -12.2 | -2.4 | -1.7 | -2.5 | -2.2 | -2.2 |
| Investing cash flow | -13.6 | -22.3 | 49.0 | -25.7 | 76.5 | -178 | -19.4 | 17.6 | 1.1 | -8.7 | -1.6 | -56.4 |
| Financing cash flow | -6.1 | -6.1 | -71.1 | -7.7 | -5.4 | 135 | -10.4 | -3.1 | -3.8 | -6.9 | -4.1 | -3.9 |
| Debt issued | 0.0 | 0.0 | 0.0 | -0.1 | -0.2 | 297 | — | — | — | — | — | — |
| Debt repaid | -3.4 | -3.2 | -67.1 | -2.5 | -160 | -2.4 | -2.5 | -2.5 | -2.4 | -2.6 | -2.4 | -2.6 |
| Effect of exchange rates | 0.1 | 0.0 | -0.2 | -0.0 | 0.0 | 0.0 | -0.2 | -0.0 | 0.5 | 0.3 | -0.6 | 0.9 |
| Net change in cash | 14.6 | -17.6 | 0.2 | -52.3 | 50.9 | -10.0 | 6.8 | -2.5 | -11.5 | 12.1 | 14.6 | -67.6 |
| Free cash flow | 30.5 | -2.4 | 9.9 | -45.2 | -34.2 | 6.5 | 24.6 | -19.4 | -10.9 | 24.9 | 18.8 | -10.4 |
| Levered free cash flow | 15.9 | -18.1 | 0.4 | -60.3 | -48.8 | -9.9 | 17.6 | -20.2 | -19.2 | 16.2 | 18.6 | -22.1 |
Financial statements of similar companies
Companies in the group: same and related industries, similar size
